Advisers today have a unique opportunity to position themselves as indispensable allies and trusted counsel to these professionals, providing the safety net they need....
Despite concerns that the popularity of pharmaceutical drug Ozempic is overblown, two fund managers are seeing stock picking opportunities from its success. ...
Investors are accused of being ‘theme junkies’ as they chase the latest mega-trend but which theme has seen the strongest returns over the past year?...
Going beyond responsible investment screens, Chris Dastoor writes, investors want to see that their manager is creating a social dividend as well as financial returns....
The COVID-19 pandemic and an ageing western world are the catalysts that will drive healthcare to be the best-performing sector over the next decade, according to SG Hisc...
Flows into thematic ETFs grew by 29% in the first half of 2021, writes Arian Neiron, as investors seek long-term investment themes....
T. Rowe Price is exploring opportunities in resources as the result of surging commodity prices and a push for electric vehicles....
The three funds would give investors exposure to areas of future growth including climate change, food production, and the growing ageing population....
Developments such as e-prescriptions and robotic surgery are accelerating the convergence between healthcare and technology which will be a key trend over the next decade...
Global healthcare stocks are expected to perform strongly over the long term thanks to a huge boost in healthcare spending across developing and developed economies trigg...
While healthcare has been one of the stand-out sectors since the start of the year and is set for further growth thanks to COVID-19 research, it is important for investor...
Platinum International Health Care manager Bianca Ogden is well placed to benefit from the COVID-19 vaccine trials as her fund holds both of the leading players. ...
As markets react to the news of a successful COVID-19 vaccine trial from US pharma Pfizer and German biotech firm BioNTech, there are just three funds holding these stock...
Healthcare and pharmaceuticals have been named as the sectors most likely to increase in value over the 12 months, according to a survey by IG, but Australians are more d...
Whether it’s through exchange traded funds or managed funds, technology has paid off as an asset class in the last year....
Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...
This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...
Interesting. Would be good to know the details of the StrategyOne deal....